20,128 Days of Data

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

CHICAGO, Oct. 4, 2019 /PRNewswire/ — Dr. Steven Fox and Healthcare Analyst Joseph Person recently presented The Power and Value of Your Data to a standing room only audience at the Home Care Association of America annual meeting in Tucson, Arizona. The presentation detailed the seismic shift in medicine and healthcare from trust to doubt and prerogative to accountability. The growth and inevitable shift to value based payment and Medicare Advantage programs was addressed. The importance of real-time patient generated health data and telehealth were validated by 20,128 days of patient data through the Home Care MetricsSMprogram.

              The Home Care MetricsSMStudy
                 N=37
                 Mean Age: 86.3 (65-104 years)
                 Number of Chronic Conditions 3.8

Medicare    

HCM

           30 Day Readmission Rate      

13.9%

0.25%

           30 Day Fall Rate

36.9%

0.25%

           30 Day ER Visits Rate            

18.2%

0.93%

Home Care MetricsSM is a telehealth platform use by complex chronically ill patients to prevent and avoid hospitalizations and emergency room care.

Contact:
Steven C. Fox D.O., Home Care MetricsSM
Phone: 312-953-5202
Email: 224226@email4pr.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/20-128-days-of-data-300931064.html

SOURCE Home Care Metrics

Staff

Recent Posts

Tebra Launches AI Note Assist, Reducing Clinical Documentation Time by 50% for Independent Practices

New HIPAA-compliant AI technology integrated into Tebra’s EHR platform reduces documentation time by up to…

2 hours ago

New Multicenter Study Demonstrates SyMRI’s Potential to Transform Clinical Neuroimaging Workflows

LINKÖPING, Sweden, June 3, 2025 /PRNewswire/ -- SyntheticMR AB (publ) is proud to share the…

2 hours ago

Asgard Therapeutics strengthens its Board of Directors and Advisory Board with leading experts in drug development and cancer immunotherapy

Highly experienced biopharma executive Dr Cristina Csimma joins Asgard's Board of Directors, while esteemed immunologists…

2 hours ago

Sixth Global Pharma Company Selects LifeSphere NavaX for GenAI-Driven Case Processing

Top 25 Global Life Science Organization Adopts NavaX, Demonstrating Industry Confidence in Scalable, GenAI-Enabled Technologies…

2 hours ago

CareLineLive Secures Majority Investment from Technology Investment Firm Accel-KKR

LONDON and MENLO PARK, Calif., June 3, 2025 /PRNewswire/ -- CareLineLive, an all-in-one home care…

2 hours ago